|
Volumn 103, Issue 1, 2010, Pages 7-8
|
Tissue factor inhibition: Another approach reducing thrombosis after vascular injury
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALT 836;
ANTICOAGULANT AGENT;
BLOOD CLOTTING FACTOR 10;
BLOOD CLOTTING FACTOR 5A;
BLOOD CLOTTING FACTOR 9;
HEPARIN;
MONOCLONAL ANTIBODY;
MONOCLONAL ANTIBODY TISSUE FACTOR;
PROTEINASE ACTIVATED RECEPTOR 2;
THROMBOPLASTIN;
UNCLASSIFIED DRUG;
ACUTE CORONARY SYNDROME;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
BLEEDING;
BLOOD FLOW;
BLOOD VESSEL INJURY;
CELL PROLIFERATION;
CELL SURVIVAL;
CHIMPANZEE;
CORONARY ARTERY DISEASE;
CYTOPLASM;
DRUG BINDING SITE;
DRUG EFFICACY;
EDITORIAL;
EXPERIMENTAL MODEL;
HEMOSTASIS;
METASTASIS;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN PHOSPHORYLATION;
THROMBOSIS;
THROMBUS;
TUMOR GROWTH;
VASCULAR SMOOTH MUSCLE;
ANIMALS;
ANTIBODIES, MONOCLONAL;
ANTICOAGULANTS;
BLOOD COAGULATION;
BLOOD VESSELS;
HUMANS;
THROMBOPLASTIN;
THROMBOSIS;
|
EID: 74249092932
PISSN: 03406245
EISSN: None
Source Type: Journal
DOI: 10.1160/TH09-10-0712 Document Type: Editorial |
Times cited : (3)
|
References (7)
|